Céline Lefranc

Cancer gene therapy mediated by CTS1, a p53 derivative: Advantage over wild-type p53 in growth inhibition of human tumors overexpressing MDM2

F. Lacroix, C. Bougeret, T. Huet, 2000, Cancer Gene Therapy.

The Selective Intravenous Inhibitor of the MET Tyrosine Kinase SAR125844 Inhibits Tumor Growth in MET-Amplified Cancer

J. Nicolas, F. Bégassat, C. Egile, 2014, Molecular Cancer Therapeutics.